Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invesque Ord Shs T.IVQ

Alternate Symbol(s):  MHIVF | T.IVQ.DB.U | T.IVQ.DB.V

Invesque Inc. is a healthcare real estate company. The Company is focused on investing in a portfolio of North American properties across the health care spectrum. The Company's portfolio includes investments in independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties, which are operated under long-term leases and joint venture arrangements with operating partners. Its portfolio also includes investments in owner-occupied seniors housing properties in which the Company owns the real estate and provides management services through its subsidiary management company, Commonwealth Senior Living. The Company owns or has a majority interest in a portfolio of approximately 68 properties in the United States, comprised of 57 assisted living and memory care facilities, nine skilled nursing facilities and two medical office buildings.


TSX:IVQ - Post by User

Post by pjn0987654321on Dec 20, 2022 8:45am
397 Views
Post# 35181666

Active on NCIB

Active on NCIB"Under Invesque's normal course issuer bid expiring December 21, 2022, Invesque received approval from the TSX to purchase for cancellation up to a maximum of 2,811,814 Shares, or approximately 5% of Invesque's 56,236,292 outstanding Shares at the time of approval, and up to a maximum of US$5,000,000 aggregate principal amount of Debentures, or approximately 10% of the public float of US$50,000,000 aggregate principal amount of Debentures outstanding at the time of approval. As of the date hereof, Invesque had repurchased and cancelled 559,800 Shares, at a weighted average purchase price of approximately $1.31 per Share, and US$1,639,000 aggregate principal amount of Debentures, at a weighted average purchase price of approximately $80.80 per $100 principal amount of Debentures through market purchases on the TSX and other Canadian alternative trading systems."

They are renewing their NCIB for 2023.

https://money.tmx.com/en/quote/IVQ/news/7915727910648844 


<< Previous
Bullboard Posts
Next >>